Carey Ng - 14 Sep 2023 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role: Director
Signature: /s/ Ilya Rachman as Attorney-In-Fact for Carey Ng
Issuer symbol: IMMX
Transactions as of: 14 Sep 2023
Net transactions value: +$25,760
Form type: 4
Filing time: 15 Sep 2023, 19:27:44 UTC
Previous filing: 14 Aug 2023
Next filing: 20 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMMX	Common Stock	Purchase	$25,760	+10,000		$2.58	10,000	14 Sep 2023	Direct	F1
holding	IMMX	Common Stock						1,025,221	14 Sep 2023	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $2.51 to $2.60, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F2	Carey Ng is the Managing Director of Mesa Verde Venture Partners III, LP ("Mesa Verde") and in such capacity has the right to vote and dispose of the securities held by such entity.

Content

This transaction was executed in multiple trades at prices ranging from $2.51 to $2.60, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Carey Ng is the Managing Director of Mesa Verde Venture Partners III, LP ("Mesa Verde") and in such capacity has the right to vote and dispose of the securities held by such entity.